These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 30314596

  • 21. Imaging the aetiology of sleep disorders in dementia and Parkinson's disease.
    Pavese N.
    Curr Neurol Neurosci Rep; 2014 Dec; 14(12):501. PubMed ID: 25341374
    [Abstract] [Full Text] [Related]

  • 22. PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.
    Pagano G, Yousaf T, Politis M.
    Curr Neurol Neurosci Rep; 2017 Oct 03; 17(11):90. PubMed ID: 28975571
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serotonergic imaging in Parkinson's disease.
    de Natale ER, Wilson H, Politis M.
    Prog Brain Res; 2021 Oct 03; 261():303-338. PubMed ID: 33785134
    [Abstract] [Full Text] [Related]

  • 28. New insight into the therapeutic role of the serotonergic system in Parkinson's disease.
    Ohno Y, Shimizu S, Tokudome K, Kunisawa N, Sasa M.
    Prog Neurobiol; 2015 Nov 03; 134():104-21. PubMed ID: 26455457
    [Abstract] [Full Text] [Related]

  • 29. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T, Wilson H, Politis M.
    Int Rev Neurobiol; 2017 Nov 03; 133():179-257. PubMed ID: 28802921
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ.
    Eur J Neurol; 2007 May 03; 14(5):523-8. PubMed ID: 17437611
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Serotonin and molecular neuroimaging in humans using PET.
    Saulin A, Savli M, Lanzenberger R.
    Amino Acids; 2012 Jun 03; 42(6):2039-57. PubMed ID: 21947614
    [Abstract] [Full Text] [Related]

  • 36. Molecular Imaging of the Noradrenergic System in Idiopathic Parkinson's Disease.
    Nahimi A, Kinnerup MB, Sommerauer M, Gjedde A, Borghammer P.
    Int Rev Neurobiol; 2018 Jun 03; 141():251-274. PubMed ID: 30314598
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.
    Beaudoin-Gobert M, Epinat J, Météreau E, Duperrier S, Neumane S, Ballanger B, Lavenne F, Liger F, Tourvielle C, Bonnefoi F, Costes N, Bars DL, Broussolle E, Thobois S, Tremblay L, Sgambato-Faure V.
    Brain; 2015 Sep 03; 138(Pt 9):2632-47. PubMed ID: 26117365
    [Abstract] [Full Text] [Related]

  • 39. Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease.
    Jang W, Park J, Shin KJ, Kim JS, Kim JS, Youn J, Cho JW, Oh E, Ahn JY, Oh KW, Kim HT.
    J Neurol Sci; 2014 Feb 15; 337(1-2):47-54. PubMed ID: 24289887
    [Abstract] [Full Text] [Related]

  • 40. Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    Joling M, van den Heuvel OA, Berendse HW, Booij J, Vriend C.
    J Neurol Neurosurg Psychiatry; 2018 Jan 15; 89(1):89-94. PubMed ID: 28899958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.